Zahra Mansouri

Dr. Zahra Mansouri


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2025 in Cancer Reports
Verified
Journal Article
Open access
MAMojtaba Aghaei
Mojtaba Aghaei
MJMohammad Ali JalaliFar
Mohammad Ali JalaliFar
AAarshid yousefi avarvand
arshid yousefi avarvand
SBSeyed Sobhan Bahreiny
Seyed Sobhan Bahreiny
NKNegin Karamali
Negin Karamali
EBEbrahim Babadi
Ebrahim Babadi
Background: Vascular endothelial growth factor‐A (VEGF‐A), In combination with other pro‐angiogenic factors, plays a pivotal role in angiogenesis and the pathogenesis of acute lymphoblastic leukemia (ALL).Aims: This meta‐analysis aims to evaluate the diagnostic value of VEGF‐A and its prognostic relevance in the outcome of patients with ALL.Methods and Results: A comprehensive literature search was conducted up to January 2025 across multiple databases. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were pooled using a random‐effects model to quantify effect sizes. Subgroup analyses and meta‐regression were employed to explore heterogeneity sources. Data extracted from 15 studies encompassing 674 patients with ALL demonstrated a significant correlation between elevated VEGF‐A levels and unfavorable prognosis (SMD: 0.878; 95% CI: 0.276–1.479; p = 0.004). Notably, increased VEGF‐A levels were particularly evident in pediatric patients older than 8 years (SMD: 0.758; 95% CI: 0.178–1.338; p = 0.010).Conclusion: The results indicate that heightened VEGF‐A expression is associated with poorer clinical outcomes in ALL, supporting its utility as a diagnostic and prognostic biomarker in this patient population.

12 March 2025 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
SBSeyed Sobhan Bahreiny
Seyed Sobhan Bahreiny
MBMohammad Navid Bastani
Mohammad Navid Bastani
HKHossein Keyvani
Hossein Keyvani
RFReza Mohammadpour Fard
Reza Mohammadpour Fard
MAMojtaba Aghaei
Mojtaba Aghaei
EHElnaz Harooni
Elnaz Harooni
Numerous studies have reported vascular endothelial growth factor A (VEGF-A) has a significant impact on the pathophysiology of COVID-19. The objective of this systematic review and meta-analysis is to determine the prognostic value of increased levels of VEGF-A in individuals with COVID-19. A systematic literature search was conducted across multiple electronic databases, including PubMed, Web of Science, Cochrane Library, Scopus, EMBASE, and Google Scholar, up to January 2024. Studies examining the levels of VEGF-A in the serum or plasma of COVID-19 patients were incorporated, with specific attention given to contrasting severe/critical cases against moderate cases. Standardized mean differences (SMD) with 95% confidence intervals (CIs) were calculated using a random-effects model to determine overall effect sizes. Meta-regressions and subgroup analyses were performed to explore potential sources of heterogeneity. The meta-analysis synthesized data from 11 studies involving a total of 1119 COVID-19 patients. Elevated levels of VEGF-A were significantly associated with disease severity, with a pooled SMD of 0.525 (95% CI 0.239–0.058; P = 0.028). Research has indicated that the nature of the relationship differs among various age groups, and there were minor discrepancies in the techniques employed to obtain VEGF-A measurements. Furthermore, meta-regression analysis indicated a potential correlation between VEGF-A levels and assay technique and body mass index (BMI). This meta-analysis provides compelling evidence for the prognostic potency of VEGF-A in COVID-19. Understanding the intricate interplay between VEGF-A and COVID-19 pathophysiology holds promise for the development of targeted therapeutic strategies and prognostic indicators in the management of COVID-19.

16 December 2024 in Biomarkers in Medicine
Verified
Journal Article
Closed access
MBMohammad Navid Bastani
Mohammad Navid Bastani
SJShahram Jalilian
Shahram Jalilian
SBSeyed Sobhan Bahreiny
Seyed Sobhan Bahreiny
MMManoochehr Makvandi
Manoochehr Makvandi
MAMojtaba Aghaei
Mojtaba Aghaei
EHElnaz Harooni
Elnaz Harooni
Surfactant Protein D (SP-D), a key component of the innate immune system, has attracted significant interest for its potential role in the pathophysiology and prognosis of COVID-19. This systematic review and meta-analysis aim to clarify the prognostic importance of SP-D levels in COVID-19 patients. A comprehensive literature search was conducted using PubMed, Web of Science, Cochrane Library, Scopus, EMBASE, and Google Scholar, covering studies published from January 2000 to January 2024. The inclusion criteria focused on studies measuring SP-D levels in the serum or plasma of COVID-19 patients, comparing severe and non-severe cases. Standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated using a random-effects model to assess overall effect sizes. Meta-regressions and subgroup analyses were performed to identify potential sources of heterogeneity, including patient age, assay techniques, and gender ratio. The meta-analysis incorporated data from nine studies involving 5,410 COVID-19 patients. Elevated SP-D levels were significantly correlated with increased disease severity, yielding an SMD of 0.642 (95% CI: 0.314 to 0.870; p = 0.012). This meta-analysis confirms the prognostic significance of SP-D in the context of COVID-19. Elevated SP-D levels are associated with severe disease outcomes, highlighting its potential as a prognostic biomarker.

7 June 2025 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PRParisa Rashidi
Parisa Rashidi
MKMohammad Ali Khaksar
Mohammad Ali Khaksar
NANarges Atefipour
Narges Atefipour
MRmaryam radan
maryam radan
FDFereshteh Negad dehbashi
Fereshteh Negad dehbashi
ZMZahra Mansouri
Zahra Mansouri
Background: Chronic obstructive pulmonary disease (COPD) is a global health concern characterized by oxidative stress and inflammation leading to lung tissue damage. Elastase contributes to the progression of COPD by increasing reactive oxygen species (ROS) and degrading elastin. Selegiline, due to its antioxidant properties, demonstrates potential therapeutic benefits in COPD by modulating oxidative stress and improving lung function. Objectives: This study investigated selegiline’s ability to reduce oxidative stress in A549 lung epithelial cells via the NRF2/Keap1 pathway, focusing on the percentage change in ROS levels and the fold-change in NRF2 and Keap1 mRNA expression. Methods: Human lung epithelial A549 cells were cultured under standard conditions in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS and antibiotics. Six groups were established: Control, H2O2, elastase, and elastase co-treated with selegiline (20, 30, and 40 µM). Cell viability, ROS levels, catalase (CAT) activity, and mRNA expression of NRF2 and Keap1 were assessed using qRT-PCR, with GAPDH as the reference gene. Results: Elastase significantly increased ROS production and lipid peroxidation while suppressing antioxidant activity via downregulating NRF2 and Keap1 mRNA expression. Selegiline treatment, particularly at 20 µM, reduced ROS levels (P < 0.001), increased CAT activity (P < 0.001), significantly increased NRF2, and decreased Keap1 gene expression (P < 0.001), compared to the elastase group. Conclusions: Selegiline mitigates elastase-induced damage, suggesting its potential as a therapeutic agent for COPD. Selegiline also ameliorates the damaging impact of elastase on A549 cells by regulating the expression of the NRF2/Keap1 pathway. Hence, in vivo studies are recommended to confirm clinical relevance.

11 August 2026 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
SSShokouh Shayanpour
Shokouh Shayanpour
MRmaryam radan
maryam radan
ZMZahra Mansouri
Zahra Mansouri
MKMohammad Ali Khaksar
Mohammad Ali Khaksar
PRParisa Rashidi
Parisa Rashidi
SSShokouh of Shayanpour
Shokouh of Shayanpour
Bisphenol A (BPA) is an environmental toxicant known to induce nephrotoxicity primarily through oxidative stress–mediated inflammation and apoptosis.